TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ELTX

Elicio Therapeutics Inc.

Healthcare · Biotechnology

1.90$ +0.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ELTX
Line item 2012 2013 2018 2019 2020 2021 2022 2023 2024 2025
– +77.7% -523.8% – – – – – – –
– -0.6% -99.6% +24,700.0% +26.6% -60.0% +320.4% +10.7% +0.7% -4.2%
– – – – +109.9% +102.9% -6.3% +103.6% +23.2% +85.7%
– – – – +115.4% +276.3% +282.9% – – –
– – +828.3% +215.7% +164.3% -96.6% -117.2% – – -187.0%
– -63.2% -100.0% – -83.1% +1,181.4% +24.5% -89.9% +31.8% -81.6%
– +41.6% – – -83.1% +1,181.4% +24.5% -95.1% +162.5% -81.0%
– – – – -90.4% – – – +266.0% –
– – – – +0.0% +0.0% -100.0% – +97.3% -100.0%
– +173.0% – -84.6% +971.8% -63.0% +9.3% +82.1% +9.6% -13.3%
– +11.0% +3,493.2% -185.0% – -117.5% – – -11.8% -104.5%
– +84.3% -527.8% – – – – – – –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?